These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 21349276)

  • 21. Brain functional connectivity and the pathophysiology of schizophrenia.
    Angelopoulos E
    Psychiatriki; 2014; 25(2):91-4. PubMed ID: 25035177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery.
    Hajós M
    Trends Pharmacol Sci; 2006 Jul; 27(7):391-8. PubMed ID: 16766049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing.
    Gallinat J; Winterer G; Herrmann CS; Senkowski D
    Clin Neurophysiol; 2004 Aug; 115(8):1863-74. PubMed ID: 15261865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How much does phase resetting contribute to event-related EEG abnormalities in schizophrenia?
    Doege K; Jansen M; Mallikarjun P; Liddle EB; Liddle PF
    Neurosci Lett; 2010 Aug; 481(1):1-5. PubMed ID: 20600621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural oscillations as a translational tool in schizophrenia research: rationale, paradigms and challenges.
    Phillips KG; Uhlhaas PJ
    J Psychopharmacol; 2015 Feb; 29(2):155-68. PubMed ID: 25567552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients.
    Boutros NN; Brockhaus-Dumke A; Gjini K; Vedeniapin A; Elfakhani M; Burroughs S; Keshavan M
    Schizophr Res; 2009 Sep; 113(2-3):339-46. PubMed ID: 19524407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmented gamma band auditory steady-state responses: support for NMDA hypofunction in schizophrenia.
    Hamm JP; Gilmore CS; Clementz BA
    Schizophr Res; 2012 Jun; 138(1):1-7. PubMed ID: 22542616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique contributions of sensory discrimination and gamma synchronization deficits to cognitive, clinical, and psychosocial functional impairments in schizophrenia.
    Koshiyama D; Miyakoshi M; Thomas ML; Joshi YB; Molina JL; Tanaka-Koshiyama K; Sprock J; Braff DL; Swerdlow NR; Light GA
    Schizophr Res; 2021 Feb; 228():280-287. PubMed ID: 33493776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency-specific disruptions of neuronal oscillations reveal aberrant auditory processing in schizophrenia.
    Hayrynen LK; Hamm JP; Sponheim SR; Clementz BA
    Psychophysiology; 2016 Jun; 53(6):786-95. PubMed ID: 26933842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia.
    Sohal VS
    Am J Psychiatry; 2022 Apr; 179(4):267-276. PubMed ID: 35360913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents.
    Black MD; Stevens RJ; Rogacki N; Featherstone RE; Senyah Y; Giardino O; Borowsky B; Stemmelin J; Cohen C; Pichat P; Arad M; Barak S; De Levie A; Weiner I; Griebel G; Varty GB
    Psychopharmacology (Berl); 2011 May; 215(1):149-63. PubMed ID: 21181124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
    Martin LF; Kem WR; Freedman R
    Psychopharmacology (Berl); 2004 Jun; 174(1):54-64. PubMed ID: 15205879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.
    Park EJ; Han SI; Jeon YW
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):674-80. PubMed ID: 20304022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.
    McNally JM; McCarley RW
    Curr Opin Psychiatry; 2016 May; 29(3):202-10. PubMed ID: 26900672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auditory steady state responses in a schizophrenia rat model probed by excitatory/inhibitory receptor manipulation.
    Vohs JL; Chambers RA; O'Donnell BF; Krishnan GP; Morzorati SL
    Int J Psychophysiol; 2012 Nov; 86(2):136-42. PubMed ID: 22504207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-frequency oscillations and the neurobiology of schizophrenia.
    Uhlhaas PJ; Singer W
    Dialogues Clin Neurosci; 2013 Sep; 15(3):301-13. PubMed ID: 24174902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steady state responses: electrophysiological assessment of sensory function in schizophrenia.
    Brenner CA; Krishnan GP; Vohs JL; Ahn WY; Hetrick WP; Morzorati SL; O'Donnell BF
    Schizophr Bull; 2009 Nov; 35(6):1065-77. PubMed ID: 19726534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunctional prefrontal gamma-band oscillations reflect working memory and other cognitive deficits in schizophrenia.
    Senkowski D; Gallinat J
    Biol Psychiatry; 2015 Jun; 77(12):1010-9. PubMed ID: 25847179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.